Catalyst Biosciences (CBIO) Reports Q2 Loss of $0.42/Share
Catalyst Biosciences (NASDAQ: CBIO) reported Q2 EPS of ($0.42), versus ($4.60) reported last year.
For earnings history and earnings-related data on Catalyst Biosciences (CBIO) click here.
Catalyst Biosciences (NASDAQ: CBIO) reported Q2 EPS of ($0.42), versus ($4.60) reported last year.
For earnings history and earnings-related data on Catalyst Biosciences (CBIO) click here.